The Current Ratio as of November 2024 (TTM) for Revelation Biosciences, Inc. (REVB) is 1.64

According to Revelation Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.64. This represents a change of -14.94% compared to the average of 1.93 of the last 4 quarters.

Revelation Biosciences, Inc. (REVB) Historical Current Ratio (quarterly & annually)

How has REVB Current Ratio performed in the past?

The mean historical Current Ratio of Revelation Biosciences, Inc. over the last ten years is 1.62. The current 1.64 Current Ratio has changed 9.99% with respect to the historical average. Over the past ten years (40 quarters), REVB's Current Ratio was at its highest in in the September 2020 quarter at 10.41. The Current Ratio was at its lowest in in the June 2020 quarter at 0.

Revelation Biosciences, Inc. (REVB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Revelation Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revelation Biosciences, Inc. (REVB) Average Current Ratio

How has REVB Current Ratio performed in the past?

The current Current Ratio of Revelation Biosciences, Inc. (REVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revelation Biosciences, Inc. (REVB) Current Ratio vs. Peers

How is REVB’s Current Ratio compared to its peers?

Revelation Biosciences, Inc.’s Current Ratio is less than Virax Biolabs Group Limited (25.94), greater than Blue Water Vaccines, Inc. (0.54), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (8.97), greater than ZyVersa Therapeutics, Inc. (0.03), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Altamira Therapeutics Ltd. (1.38), less than Zura Bio Limited (10.36), less than Phio Pharmaceuticals Corp. (6.38), greater than TransCode Therapeutics, Inc. (1.58), less than Quoin Pharmaceuticals, Ltd. (3.02), greater than PaxMedica, Inc. Common Stock (0.38),

Build a custom stock screener for Revelation Biosciences, Inc. (REVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revelation Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revelation Biosciences, Inc. (REVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revelation Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.